A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder. The study, published in Nature Communications, reveals that a defect ...

Ingelise Saunders, Chair of BOOST Pharma, said: “Hans’ transition to CEO comes at a pivotal time for the company. With his ...

A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder. The study, published in Nature Communications, reveals that a defect ...

A teenager who lived in southern Europe around 12,000 years ago has become the earliest person in history to receive a genetic diagnosis. Ancient DNA from her skeleton has revealed a rare form of ...

A new study has unveiled the crucial role of low-density lipoprotein receptor-related protein 1 (LRP1) in skeletal development. Researchers have found that a deficiency of LRP1 in skeletal progenitor ...

Skeletal muscle channelopathies and myotonic disorders constitute a heterogeneous group of neuromuscular conditions caused by mutations that impair the function of ion channels, including sodium and ...

Patients with schizophrenia experience osteoporosis at rates far exceeding the general population, yet clinicians have lacked genetic explanations for this apparent relationship. Researchers headed by ...

Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and ...

NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a ...

Skeletal muscle and cardiovascular diseases continue to pose significant challenges to public health, affecting a wide range ...